Enhanced intestinal absorption of daidzein by borneol/menthol eutectic mixture and microemulsion

AAPS PharmSciTech

Volumn 12, Issue 4, 2011, Pages 1044-1049

  Shen, Qi ^a   Li, Xi ^a   Li, Wenji ^a   Zhao, Xinyi ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

absorption enhancer; bioavailability; borneol menthol eutectic mixture; daidzein; microemulsion

Indexed keywords

BORNEOL; CREMOPHOR; DAIDZEIN; MACROGOL 400; MENTHOL; OLEIC ACID ETHYL ESTER; VERAPAMIL; WATER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG BIOAVAILABILITY; DRUG TRANSPORT; INTESTINE ABSORPTION; MALE; MEMBRANE PERMEABILITY; MICROEMULSION; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; BORNANES; CHEMISTRY, PHARMACEUTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMPOUNDING; EMULSIONS; INTESTINAL ABSORPTION; INTESTINES; ISOFLAVONES; MALE; METHANOL; OILS; OLEIC ACIDS; P-GLYCOPROTEIN; POLYETHYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY; SURFACE-ACTIVE AGENTS; TECHNOLOGY, PHARMACEUTICAL; VERAPAMIL; WATER;

EID: 83555174908     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-011-9672-4     Document Type: Article

References (43)

1. BJ Aungst 1993 Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism J Pharm Sci 82 979 987 8254497 10.1002/jps.2600821002 1:CAS:528: DyaK3sXmslynt7o%3D (Pubitemid 23314099)
2. VHL Lee A Yamamoto 1990 Penetration and enzymatic barriers to peptide and protein absorption Adv Drug Deliv Rev 4 171 207 10.1016/0169-409X(89)90018-5 1:CAS:528:DyaK3cXhtVClsLo%3D
3. H Asada T Douen M Waki S Adachi T Fujita A Yamamoto 1995 Absorption characteristics of chemically modified-insulin derivatives with various fatty acids in the small and large intestine J Pharm Sci 84 682 687 7562404 10.1002/jps.2600840604 1:CAS:528:DyaK2MXlslyktLo%3D
4. J Wang D Chow H Heiati WC Shen 2003 Reversible lipidization for the oral delivery of salmon calcitonin J Control Release 88 369 380 12644363 10.1016/S0168-3659(03)00008-7 1:CAS:528:DC%2BD3sXitVGhsLo%3D (Pubitemid 36331879)
5. H Araya M Tomita M Hayashi 2005 The novel formulation design of O/W microemulsion for improving the gastrointestinal absorption of poorly water soluble compounds Int J Pharm 305 61 74 16219433 10.1016/j.ijpharm.2005.08.022 1:CAS:528:DC%2BD2MXhtFOhurzO (Pubitemid 41562218)
6. YM Yin FD Cui CF Mu MK Choi JS Kim SJ Chung CK Shim 2009 Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation J Control Release 140 86 94 19709639 10.1016/j.jconrel.2009.08. 015 1:CAS:528:DC%2BD1MXhtlOks73E
7. VHL Lee A Yamamoto UB Kompella 1991 Mucosal penetration enhancers for facilitation of peptide and protein drug absorption Crit Rev Ther Drug Carrier Syst 8 91 192 1934087 1:CAS:528:DyaK3MXmtl2gtbY%3D
8. CS Yong CH Yang JD Rhee 2004 Enhanced rectal bioavailability of ibuprofen in rats by poloxamer 188 and menthol Int J Pharm 269 169 176 14698588 10.1016/j.ijpharm.2003.09.013 1:CAS:528:DC%2BD3sXpvFektL8%3D (Pubitemid 38032832)
9. XY Yu QN Ping ZP Chen 2007 The enhancing effect of synthetical borneol on the absorption of tetramethylpyrazine phosphate in mouse Int J Pharm 337 74 79 10.1016/j.ijpharm.2006.12.034 (Pubitemid 46756038)
10. FZ Li J Feng QY Cheng WJ Zhu 2007 Delivery of 125I-cobrotoxin after intranasal administration to the brain: a microdialysis study in freely moving rats Int J Pharm 328 161 167 17049426 10.1016/j.ijpharm.2006.08.011 1:CAS:528:DC%2BD28XhtlWqurbP (Pubitemid 44880574)
11. H Adlercreutz 1995 Phytoestrogens: epidemiology and a possible role in cancer protection Environ Health Perspect 103 103 112 8593855 1:CAS:528:DyaK28XlvFeitA%3D%3D
12. L Coward N Barnes KDR Setchell S Barnes 1993 Genistein and daidzein, and their β-glycoside conjugates: anti-tumor isoflavones in soybean foods from American and Asian diets J Agric Food Chem 41 1961 1967 10.1021/jf00035a027 1:CAS:528:DyaK3sXmsVymsLo%3D (Pubitemid 2007019)
13. KDR Setchell AM Lawson SP Borriello R Harkness 1981 Lignan formation in man-microbial involvement and possible roles in relation to cancer Lancet 2 4 7 6113409 10.1016/S0140-6736(81)90250-6 1:CAS:528:DyaL38XhslOisw%3D%3D (Pubitemid 11038678)
14. JN Wilcox BF Blumenthal 1995 Thrombotic mechanisms in atherosclerosis: potential impact of soy proteins J Nutr 125 631S 638S 7884545 1:CAS:528:DyaK2MXktFGmu7w%3D
15. R Fatemeh D Christy P Miseon 2003 Variations in metabolism of the soy isoflavonoid daidzein by human intestinal microfloras from different individuals Arch Microbiol 180 11 16 10.1007/s00203-003-0551-6 (Pubitemid 36871777)
16. R King D Bursill 1998 Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans Am J Clin Nutr 67 867 72 9583843 1:CAS:528:DyaK1cXislaju7k%3D (Pubitemid 28196660)
17. K Setchell N Brown P Desai 2001 Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements J Nutr 131 1362 1375S
18. S Shelnutt C Cimino P Wiggins T Badger 2000 Urinary pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein Cancer Epidemiol Biomarkers Prev 9 413 419 10794486 1:CAS:528:DC%2BD3cXjt1Cks7o%3D (Pubitemid 30265785)
19. K Setchell N Brown P Desai 2003 Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes J Nutr 133 1027 1035 12672914 1:CAS:528:DC%2BD3sXivVekurw%3D (Pubitemid 36407120)
20. Q Shen X Li D Yuan W Jia 2010 Enhanced oral bioavailability of daidzein by self-microemulsifying drug delivery system Chem Pharm Bull 58 639 643 20460789 10.1248/cpb.58.639 1:CAS:528:DC%2BC3cXovVWktbk%3D
21. GM Grass SA Sweetana 1998 A correlation of permeabilities for passively transported compounds in monkey and rabbit jejunum Pharm Res 5 372 376 10.1023/A:1015911712079
22. H Saitoh BJ Aungst 1995 Possible involvement of multiple P-glycoprotein mediated efflux systems in the transport of verapamil and other organic cations across rat intestine Pharm Res 12 1304 1310 8570526 10.1023/A:1016217505990 1:CAS:528:DyaK2MXpslOitL0%3D
23. Y Shono H Nishihara Y Matsuda S Furukawa N Okada T Fujita 2004 Modulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes J Pharm Sci 93 877 885 14999725 10.1002/jps.20017 1:CAS:528: DC%2BD2cXivF2lsbo%3D (Pubitemid 38420399)
24. F Faassen G Vogel H Spanings H Vromans 2003 Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs Int J Pharm 263 113 122 12954186 10.1016/S0378-5173(03)00372-7 1:CAS:528: DC%2BD3sXmvValtL0%3D (Pubitemid 37087938)
25. E Liang K Chessic M Yazdanian 2000 Evaluation of an accelerated Caco-2 cell permeability model J Pharm Sci 89 336 345 10707014 10.1002/(SICI)1520- 6017(200003)89:3<336::AID-JPS5>3.0.CO;2-M 1:CAS:528:DC%2BD3cXit1Knt7c%3D (Pubitemid 30152434)
26. Q Shen Y Lin T Handa M Doi 2006 Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies Int J Pharm 313 49 56 16500056 10.1016/j.ijpharm. 2006.01.020 1:CAS:528:DC%2BD28XjtVGqurg%3D
27. L Zhang Y Zheng MS Chow Z Zuo 2004 Investigation of intestinal absorption and disposition of green tea catechins by Caco-2 monolayer model Int J Pharm 287 1 12 15541906 10.1016/j.ijpharm.2004.08.020 1:CAS:528:DC%2BD2cXps1Oqt7g%3D (Pubitemid 39487237)
28. CD Allred NC Twaddle KF Allred TS Goeppinger 2005 Soy processing affects metabolism and disposition of dietary isoflavones in ovariectomized BALB/c mice J Agric Food Chem 53 8542 8550 16248551 10.1021/jf051246w 1:CAS:528: DC%2BD2MXhtVKmtLnF (Pubitemid 41608911)
29. P Janning US Schuhmacher A Upmeier P Diel H Michna GH Degen 2000 Toxicokinetics of the phytoestrogen daidzein in female DA/Han rats Arch Toxicol 74 421 430 11097378 10.1007/s002040000149 1:CAS:528:DC%2BD3cXos1arur8%3D
30. F Qiu XY Chen B Song DF Zhong CX Liu 2005 Influence of dosage forms on pharmacokinetics of daidzein and its main metabolite daidzein-7-O-glucuronide in rats Acta Pharmacol Sin 26 1145 1152 16115384 10.1111/j.1745-7254.2005.00187.x 1:CAS:528:DC%2BD2MXhtVWktbnM (Pubitemid 41296956)
31. Y Zheng SO Lee MA Verbruggen PA Murphy S Hendrich 2004 The apparent absorptions of isoflavone glucosides and aglucons are similar in women and are increased by rapid gut transit time and low fecal isoflavone degradation J Nutr 134 2534 2539 15465743 1:CAS:528:DC%2BD2cXosV2jt7o%3D (Pubitemid 39315251)
32. YB Ge Y Ma WZ Li 2009 Transport and metabolism of daidzein in Caco-2 cell model J Chinese Medicinal Materials. 32 1563 1567 1:CAS:528: DC%2BC3cXhvVCmsrk%3D
33. MVS Varma S Khandavilli Y Ashokraj A Jain A Dhanikula 2004 Biopharmaceutic classification system: a scientific framework for pharmacokinetic optimization in drug research Curr Drug Metab 5 375 388 15544432 10.2174/1389200043335423 1:CAS:528:DC%2BD2cXnvFars7k%3D (Pubitemid 39276602)
34. MM Nerurkar NF Ho PS Burton TJ Vidmar RT Borchardt 1997 Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport of a model peptide in Caco-2 cells J Pharm Sci 86 813 821 9232522 10.1021/js960483y 1:CAS:528:DyaK2sXjslCktrk%3D (Pubitemid 27297493)
35. BD Rege JP Kao JE Polli 2002 Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers Eur J Pharm Sci 16 237 246 12208453 10.1016/S0928-0987(02)00055-6 1:CAS:528:DC%2BD38Xms1ynsro%3D
36. LS Kang HW Jun JW McCall 2000 Physicochemical studies of lidocaine-menthol binary systems for enhanced membrane transport Int J Pharm 206 35 42 11058808 10.1016/S0378-5173(00)00505-6 1:CAS:528:DC%2BD3cXnsl2rsro%3D
37. NH Shah MT Carvajal CI Patel MH Infeld AW Malick 1994 Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs Int J Pharm 106 15 23 10.1016/0378-5173(94)90271-2 1:CAS:528:DyaK2cXjtlSqu74%3D (Pubitemid 24110060)
38. PP Constantinides 1995 Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects Pharm Res 12 1561 1572 8592652 10.1023/A:1016268311867 1:CAS:528:DyaK2MXpslCqsrs%3D (Pubitemid 26005509)
39. K Kawakami T Yoshikawa T Hayashi Y Nishihara K Masuda 2002 Microemulsion formulation for enhanced absorption of poorly soluble drugs II. In vivo study J Control Release 81 75 82 11992680 10.1016/S0168-3659(02)00050-0 1:CAS:528:DC%2BD38XjtFyhsbc%3D (Pubitemid 34454851)
40. J Shaikh D Ankola V Beniwal D Singha M Kumar 2009 Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer Eur J Pharm Sci 37 223 230 19491009 10.1016/j.ejps.2009.02.019 1:CAS:528: DC%2BD1MXms1Oksrg%3D
41. J Italia M Yahya D Singh M Kumar 2009 Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous fungizone Pharm Res 26 1324 1331 19214716 10.1007/s11095-009- 9841-2 1:CAS:528:DC%2BD1MXhvVCqsLo%3D
42. A Singh A Chaurasiya G Jain A Awasthi D Asati G Mishra R Khar R Mukherjee 2009 High performance liquid chromatography method for the pharmacokinetic study of bicalutamide SMEDDS and suspension formulations after oral administration to rats Talanta 78 1310 1314 19362193 10.1016/j.talanta.2009.01. 058 1:CAS:528:DC%2BD1MXksVWhsro%3D
43. C Wu Q Huang H Qi S Hou 2005 Ocular toxicity of borneol in rabbits Chin. Pharm. J. 40 1710 1713 (Pubitemid 43219650)